IRUS Total

Lung cancer mortality in Europe and the United States between 2000 and 2017: an observational analysis

File Description SizeFormat 
00311-2021.full.pdfPublished version623.83 kBAdobe PDFView/Open
Title: Lung cancer mortality in Europe and the United States between 2000 and 2017: an observational analysis
Authors: Jani, C
Marshall, D
Singh, H
Goodall, R
Shalhoub, J
Al Omari, O
Salciccioli, J
Thomson, C
Item Type: Journal Article
Abstract: Background The lung is the most common site for cancer and has the highest worldwide cancer-related mortality. Our study reports and compares trends in lung cancer mortality in the United States (US) and 26 European countries. Study design and methods Lung cancer mortality data were extracted for males and females for each of the years 2000–2017 from the World Health Organization (WHO) Mortality and the Centers for Disease Control and Prevention (CDC) WONDER databases. Lung cancer mortality trends were compared using Joinpoint regression analysis, and male-to-female mortality ratios were calculated. Results Down-trending lung cancer mortality rates were observed in males in all countries except Cyprus and Portugal between 2000 and 2017. In females, increasing mortality rates were observed in 22 of the 27 countries analyzed. Latvia had the highest estimated annual percentage change (EAPC) in male mortality (−9.6%) between 2013–2015. In the US, EAPCs were −5.1% for males and −4.2% for females between 2014–2017. All countries had an overall decrease in the ratio of male-to-female lung cancer mortality. The most recent observation of median male-to-female mortality was 2.26 (IQR 1.92–4.05). The countries with the greatest current sex disparity in lung cancer mortality were Lithuania (5.51) and Latvia (5.00). Conclusion Between 2000 and 2017, lung cancer mortality rates were decreasing for males in Europe and the US, whereas increasing lung cancer mortality rates were generally observed in females. There is a persistent but decreasing sex-mortality gap, with men having persistently greater lung cancer mortality but with rates decreasing faster than women. Footnotes This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Issue Date: 21-Oct-2021
Date of Acceptance: 27-Sep-2021
URI: http://hdl.handle.net/10044/1/92526
DOI: 10.1183/23120541.00311-2021
ISSN: 2312-0541
Publisher: https://openres.ersjournals.com/content/7/4/00311-2021
Start Page: 1
End Page: 14
Journal / Book Title: European Respiratory Journal Open Research
Volume: 7
Issue: 4
Copyright Statement: ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Publication Status: Published
Online Publication Date: 2021-10-21
Appears in Collections:Department of Surgery and Cancer
Faculty of Medicine

This item is licensed under a Creative Commons License Creative Commons